New Data on Cimzia certolizumab pegol to be Presented at ACG Meeting...
ATLANTA Oct. 31 2011 PRNewswire UCB a leading biopharmaceutical company at the forefront of immunology treatment and research will present new data on Cimzia&174; certolizumab pegol at the American...
View ArticleNektar Therapeutics Reports Third Quarter 2011 Financial Results
SAN FRANCISCO Calif. Nov. 2 2011 PRNewswire Nektar Therapeutics Nasdaq NKTR today reported its financial results for the third quarter ended September 30 2011. Cash cash equivalents and investments at...
View ArticleNew Data on PatientReported Improvements in Quality of Life Measures and...
ATLANTA Nov. 7 2011 PRNewswire UCB a leading biopharmaceutical company at the forefront of immunology treatment and research is proud to sponsor several key sets of Cimzia&174; certolizumab pegol...
View ArticleDiplomat Specialty Pharmacy Recipient of MichBio Good to Great Award; Also...
FLINT Mich. Nov. 7 2011 PRNewswire Diplomat Specialty Pharmacy the nation's largest privately owned specialty pharmacy announced today that they are the recipient of MichBio's Good to Great Award."The...
View ArticleCoronado Biosciences to Present at the Lazard Capital Markets 8th Annual...
BURLINGTON Mass. Nov. 8 2011 PRNewswire Coronado Biosciences Inc. a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and...
View ArticleChemoCentryx Reports Clinical Efficacy for CCX354 a Novel CCR1 Inhibitor in a...
MOUNTAIN VIEW Calif. Nov. 8 2011 PRNewswire ChemoCentryx Inc. today announced that it reported positive Phase II results for CCX354 at the Annual Meeting of the American College of Rheumatology ACR....
View ArticleChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in...
MOUNTAIN VIEW Calif. Nov. 10 2011 PRNewswire ChemoCentryx Inc. today announced positive preclinical results for its novel CCR2 antagonist at the 44th Annual Meeting of the American Society of...
View ArticleSoligenix Reports Third Quarter 2011 Financial Results
PRINCETON N.J. Nov. 14 2011 PRNewswire Soligenix Inc. OTCBB SNGX Soligenix or the Company a development stage biopharmaceutical company announced today its financial results for the third quarter of...
View ArticlePositive Data for Nektar's New MuOpioid Analgesic Molecule to Treat Acute...
SAN FRANCISCO and WASHINGTON Nov. 14 2011 PRNewswire Nektar Therapeutics NASDAQ NKTR announced today that positive preclinical data for NKTR192 a novel muopioid agonist was presented at the 41st Annual...
View ArticleCoronado Biosciences Reports Third Quarter 2011 Financial Results
BURLINGTON Mass. Nov. 15 2011 PRNewswire Coronado Biosciences Inc. a company focused on novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer today announced financial...
View ArticleNKTR102 Demonstrates Synergistic AntiTumor Activity in Combination with...
SAN FRANCISCO Nov. 15 2011 PRNewswire Nektar Therapeutics NASDAQNKTR today presented positive preclinical data for NKTR102 a nextgeneration topoisomerase I inhibitor at the 2011 AACRNCIEORTC...
View ArticleCoronado Biosciences Commences Public Trading on the OTC Bulletin Board
BURLINGTON Mass. Nov. 17 2011 PRNewswire Coronado Biosciences Inc. OTCBB CNDO a company focused on novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer today...
View ArticleRedHill Biopharma Accelerates RHB104 Phase III Study In Crohns Disease With...
Life Sciences Jobs ...
View ArticleThe Kenneth Rainin Foundation Announces 2012 Innovator Awards Program $100000...
OAKLAND Calif. Nov. 30 2011 PRNewswireUSNewswire The Kenneth Rainin Foundation announced today its 2012 Innovator Awards Program for Inflammatory Bowel Disease IBD. The program supports "outofthebox"...
View ArticleSenate Resolution Supports Misdiagnosed Digestive Diseases
Week of December 17 first Crohn's and Colitis Awareness Week NEW YORK Nov. 30 2011 PRNewswireUSNewswire &160;The week of&160; December 17 has been designated by the Crohn's & Colitis...
View ArticleCasey Abrams Announces Winners of Inflammatory Bowel Disease Awareness...
HORSHAM Pa. Dec. 2 2011 PRNewswire The winners of IBD Icons a national campaign to celebrate the achievements of those living beyond inflammatory bowel disease IBD have been decided by America after a...
View ArticleCoronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare...
BURLINGTON Mass. Dec. 7 2011 PRNewswire &160;Coronado Biosciences Inc. OTCBB CNDO a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of...
View ArticleNektar Reports Affymax Announced FDA Advisory Committee Voted in Favor of...
&160; SAN FRANCISCO Dec. 8 2011 PRNewswire Nektar Therapeutics NASDAQNKTR today reported that its partner Affymax Inc. announced that the U.S. Food and Drug Administration FDA Oncologic Drugs...
View ArticleCoronado Biosciences Announces Phase 1 Results of CNDO109 in AML to be...
BURLINGTON Mass. Dec. 8 2011 PRNewswire &160;Coronado Biosciences Inc. OTCBB CNDO a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of...
View ArticleChemoCentryx Initiates a Phase II Clinical Trial For CCX140 A Novel Inhibitor...
&160; MOUNTAIN VIEW Calif. Dec. 8 2011 PRNewswire ChemoCentryx Inc. today announced the initiation of a Phase II clinical trial for CCX140 an orallyadministered small molecule for the treatment of...
View Article